Expand BIS Menu
BIS MENU

BIS ETF Profile


Family: ProShares
Name: ProShares UltraShort Nasdaq Biotechnology
Inception Date: 7-Apr-2010
Termination Date:
Investment Objective: ProShares UltraShort Nasdaq Biotechnology seeks daily investment results before fees and expenses that correspond to twice (200%) the inverse (opposite) of the daily performance of the NASDAQ Biotechnology Index.
Prospectus
Top 10 Holdings
Derivatives offset 199.9814%
Net Other Assets (Liabilities) 100.0000%
NASDAQ Bio Index SWAP BNP -69.8290%
NASDAQ Biotechnology Index SWAP Societe Generale -51.7929%
NASDAQ Biotechnology Index SWAP Morgan Stanley & Co. International PLC -28.0291%
NASDAQ Biotechnology Index SWAP Citibank NA -26.5667%
NASDAQ Biotechnology Index SWAP UBS AG -14.9895%
NASDAQ Biotechnology Index SWAP Bank of America NA -8.7743%
Top 10 Holdings Weight: 100.0%
Number of Holdings: 8
Shares Outstanding: 171,100
Total Net Assets: 3,411,734
NAV: 19.95
Net Expense Ratio: 0.95%
Asset Class: Equities (Stocks)
Developed or Emerging: Developed Market Funds
Country: US
Region:
Strategy:
Currency:
Commodity:
Sector: Healthcare
Industry: Biotech
Dividend Type:
Tax Exempt State:
Maturity Duration:
Market Cap: Broad Market / Multi-Cap
Credit Quality:
Mortgage Bond Types:
Bond Type:
Gov't Bond Types:
Reit Type:
Leverage Direction/Factor: Inverse (-2x)
Is Currency Hedged: No
US or Ex-US: Domestic